Alex Goldberg

Gilead Sciences Inc. (NASDAQ:GILD) and Huntington Bancshares Incorporated (NASDAQ:HBAN) Added to Equity Profile Report's NASDAQ Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 01/15/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Gilead Sciences Inc. (NASDAQ:GILD) and Huntington Bancshares Incorporated (NASDAQ:HBAN).

Gilead Sciences Inc. (NASDAQ:GILD) a biopharmaceutical company that discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia is currently down (-0.04%) on 5,191,133 shares traded after U.S. FDA Accepted New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma. Gilead Sciences Inc. (NASDAQ:GILD) is currently down (-2.21%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Gilead Sciences Inc. (NASDAQ:GILD)

Huntington Bancshares Incorporated (NASDAQ:HBAN) operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services is currently up (+1.07%) on 9,331,482 shares traded. Huntington Bancshares Incorporated (NASDAQ:HBAN) is currently up (+49.77%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about Huntington Bancshares Incorporated (NASDAQ:HBAN)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com